Given that the expression of TF antigen on tumor cells promotes metastasis by interaction with galectin-3 on the endothelial cells [30], it is logical to assume that the circulating TF-specific antibody may modulate this interaction via binding with TF antigen-positive circulating tumor cells. The gene discussed is TF; the disease is neoplasm.